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Abstract: The likelihood of developing cancer during one's lifetime is ap-
proximately one in two for men and one in three for women in the United
States. Cancer is the second-leading cause of death and accounts for one in
every four deaths. Evidence-based policy planning and decision making by
cancer researchers and public health administrators are best accomplished
with up-to-date age-adjusted site-speci¯c cancer death rates. Because of the
3-year lag in reporting, forecasting methodology is employed here to esti-
mate the current year's rates based on complete observed death data up
through three years prior to the current year. The authors expand the State
Space Model (SSM) statistical methodology currently in use by the Ameri-
can Cancer Society (ACS) to predict age-adjusted cancer death rates for the
current year. These predictions are compared with those from the previous
Proc Forecast ACS method and results suggest the expanded SSM performs
well.
Key words: Age-adjusted mortality rate, local quadratic model, state space
model.
1. Introduction
This year, more than 1,500 people a day in the United States are expected
to die of cancer (American Cancer Society, 2007). Accounting for one in every
four deaths, cancer is the second-leading cause of death, exceeded only by heart
disease. Cancer is a major public health problem and estimates of up-to- date
age-adjusted cancer death rates are desired by researchers and public health ad-
ministrators involved in the war on cancer because of the need to make accurate
assessments of progress being made. However, collecting mortality data nation-
wide results in a three-year time lag in reporting mortality statistics which stems
from the time required to collect and process mortality data from all states and re-
port mortality for individual cancers. It is also important to note that additional
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resources could possibly shorten the time lag somewhat, but could not reduce it
to zero. An alternative approach involving forecasting methodology is considered
here and o®ers the possibility of obtaining reasonably accurate up-to-date cancer
mortality rates.
Each year, the American Cancer Society publishes the estimated number of
new cancer cases and deaths for the current calendar year based on projections
from observed data available through the most recent year in its publication
Cancer Facts & Figures. Studying age-adjusted cancer death rates is of interest
since cancer death counts do not account for the size of the population. The
purpose of this paper is to extend this paradigm to age-adjusted cancer death
rates. The methodology is intended to project an updated rate based on historical
data through three years prior to the current year. Statistical methodology using
the State Space Model is proposed that adjusts for short term trends at the end
of the utilized data range. However, this methodology does not consider factors
that may in°uence rate changes or recent trends. Age-adjusted cancer death
rates are projected to the current year (2007) based on data collected since 1969.
2. Cancer Mortality Data
Data on deaths in the United States are compiled by the National Center
for Health Statistics (NCHS) of the Centers for Disease Control and Prevention
(CDC)1. Cause of death is based on reasons cited on the death certi¯cate. The
process of data collection, compilation, and publication takes several years, caus-
ing up to a three year time lag in the death data available to the public. For
example, in the current year 2007, the most recent national level death ¯le avail-
able includes data from 1969 to 2004. The Surveillance, Epidemiology and End
Results (SEER) program annually obtains from NCHS a public-use ¯le containing
information on all deaths occurring in the US by calendar year2. Information on
each death includes age at death, sex, geographic area of residence, and underly-
ing and contributing causes of death. The underlying cause of death is used in the
calculation of age-adjusted death rates. Cause of death before 1999 was coded
according to ICD-9; beginning with deaths in 1999, ICD-10 was used (World
Health Organization, 1975, 1992). Age-adjusted death rates for the SEER geo-
graphic areas, for each state, and for the entire US are obtained using SEER*Stat
software available3.
1See http://www.cdc.gov/nchs/Default.htm
2See http://seer.cancer.gov/mortality
3See http://seer.cancer.gov
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3. Materials and Methods
3.1 Death rate prediction methods
The American Cancer Society (ACS) has used two di®erent methods for age-
adjusted death count projections to the current year (Wingo et al., 1998; Pickle et
al., 2003). The ¯rst method was an extension of the forecasting methodology for
age-adjusted cancer death count projections between 1995 and 2003. The second
method, which is currently in use, is based on the State Space Model (SSM)
(Tiwari et al., 2004; Ghosh et al., 2007). For our analysis, we have extended
this method to project the age-adjusted death rates, in place of age-adjusted
death counts, for the current year to overcome the three year time lag in data
availability.
Between 1995 and 2003, the American Cancer Society used the PROC FORE-
CAST procedure in the SAS software system (henceforth denoted by PF) to
project the age-adjusted cancer death counts (Ghosh and Tiwari, 2007). This
method gives three-year-ahead predictions and 95% prediction intervals for the
age-adjusted death counts. This model was easily adaptable to rates by simply
replacing the age- adjusted death counts with rates without changing the form
of the model. We explain the PF method in the following paragraph.
The age-adjusted mortality rate at time t is de¯ned as
rt =
JX
j=1
wj
dtj
ntj
;
where wj are the known standards (weights) normalized to sum to 1 and dtj
and ntj are the number of deaths and population at risk at time t and in age-
group j. Note that there are J = 19 age-groups in the SEER Program given by
0 ¡ 1; 1 ¡ 4; 5 ¡ 9; : : : ; 85+. The PF method assumes that the age-adjusted
death rates have a quadratic trend with autoregressive errors given by
rt = b0 + b1t+ b2t2 + ut;
where ut = a1ut¡1+ ¢ ¢ ¢+ aput¡p+ ²t are the autoregressive errors (Wingo et al.,
1998). Here f²tg is assumed to be an independent sequence of zero-mean, random
errors with constant variance. Model ¯tting occurs in two sequential steps. First,
the least-squares method is used to estimate the trend parameters b^0; b^1; b^2.
Then, an autoregressive model is ¯t on the residuals from this estimated model
u^t = rt ¡ b^0 ¡ b^1t¡ b^2t2. The ¯nal model so obtained was used to obtain 3-year
ahead predictions and the corresponding 95% prediction intervals. The results of
the PF presented here are the point estimate predictions obtained from PF.
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Tiwari et al. (2004) developed an alternative method for projecting age-
adjusted cancer death counts to the current year. Motivated to improve sensi-
tivity to recent short term trends and eliminate subjectivity, these authors used
a state space model method (SSM) for predicting the age-adjusted death counts.
This model is currently used by the American Cancer Society for estimating
current year counts.
The SSM is easily adapted for predicting age-adjusted death rates, with the
model for rt written as (measurement equation)
rt = ®t + ²t; (t = 1; 2; : : :);
where ®t is the unobserved trend and ²t is the (measurement) error at time t. The
²t's are assumed to be serially uncorrelated with mean 0 and constant variance
¾2t , independent of time t. Instead of using a deterministic function in PF to
model the trend, we follow the framework of Tiwari et al. (2004) and use a local
quadratic trend that changes with time. This allows the model to quickly make
adjustments and get closer to the observed series (Ghosh et al., 2007). The form
of the local quadratic time-varying trend (for t = 1; 2; : : :) is the transition
equation as follows: 8<:
®t = ®t¡1 + ¯t¡1 + °t¡1 + ´1t;
¯t = ¯t¡1 + 2°t¡1 + ´2t;
°t = °t¡1 + ´3t;
where ®t; ¯t; °t are interpreted as local intercept, slope and acceleration param-
eters respectively of the SSM, and ´kt (k = 1; 2; 3) are uncorrelated random
errors.
The prediction curve for some cancer sites displays excess variability. This is
handled with a tuning parameter in the SSM prediction model. Technical details
of incorporating the tuning parameter into the SSM can be found in Ghosh et al.
(2007).
3.2 Validation method
The comparability of the death rate predictions from the two methods (PF
and SSM) was assessed using a weighted average of the squared deviation di®er-
ences between the one-, two- and three-year-ahead projected and observed values.
Deviations for comparing di®erent cancer types are weighted by the number of
deaths for that cancer type in 2003 as given in Cancer Facts and Figures. De-
viations across time are weighted by the number of deaths in a given year. In
comparing the two average squared deviations, the one with a smaller value is an
indicator of the predicted value falling closer to the observed value. When rates
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are compared for both genders combined or for multiple cancers combined (since
the death rates vary by cancer site and gender), weighted averages of the squared
deviation di®erences were used, with the age-adjusted estimated death rate for
the most recent year used as the weight.
4. Results
4.1 Model comparison and results
Figure 1 compares the predicted Proc Forecast (PF) and State Space Model
(SSM) age-adjusted death rates for prostate cancer.
(a) (b)
(c) (d)
Figure 1: Age-adjusted death rate (per 100,000) predictions for prostate can-
cer: (a) ¯ts for 1969-1999, projections for 2000-2002; (b) ¯ts for 1969-2000,
projections for 2001-2003; (c) ¯ts for 1969-2000, projections for 2001-2003; (d)
¯ts for 1969-2004, projections for 2005-2007.
In Figure 1a, we used the data on observed age-adjusted death rates for
prostate cancers from 1969 to 1999 to ¯t the two models, and we extrapolated
one-, two-, and three-year-ahead projections for 2000, 2001, and 2002. Both
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models ¯t the observed data (1969 to 1999) fairly well. To be sure validation was
spread across several calendar years, the analysis was repeated for subsequent
years and is displayed in Figures 1a { 1d. In Figure 1b, we used observed data
from 1969 to 2000 to extrapolate death rates for 2001, 2002, and 2003, and in
Figure 1c, we used observed data from 1969 to 2001 to extrapolate death numbers
for 2002, 2003, and 2004. Finally, Figure 1d shows how the actual projections
would occur in practice, projecting out to the future where we currently have no
data to validate the results. This panel uses the most recent available data (1969
to 2004) at the time this report was written and projects through 2007.
Figure 1a shows that the SSM method has strong ability to capture short term
trends, whereas the PF predictions are poor and show an increasing trend while
the observed values are actually decreasing. Figures 1b and 1c show extremely
accurate predictions by the SSM method, with poor future predictions for the
PF method.
Table 1: Observed and three-year-ahead predictions for cancer site / sex com-
binations for 2004, using data from 1969 to 2001.
3-Yr Predicted Values
Cancer Site/Sex Combinations Observed PF SSM
Colon & Rectum (Females) 15.15 15.56 16.10
Lung & Bronchus (Females) 40.87 43.31 41.33
Melanoma of the Skin (Females) 1.70 1.69 1.69
Breast (Females) 24.38 23.84 23.80
Ovary (Females) 8.75 9.03 8.82
Hodgkin Lymphoma (Females) 0.34 0.49 0.34
Non-Hodgkin Lymphoma (Females) 5.68 7.15 5.20
Acute Lymphocytic Leukemia (Females) 0.39 0.45 0.41
Colon & Rectum (Males) 21.57 21.21 22.41
Lung & Bronchus (Males) 70.29 67.94 70.57
Melanoma of the Skin (Males) 3.94 3.92 3.83
Prostate (Males) 25.45 28.91 26.41
Testis (Males) 0.25 0.31 0.23
Hodgkin Lymphoma (Males) 0.54 0.69 0.55
Non-Hodgkin Lymphoma (Males) 8.85 11.13 8.54
Acute Lymphocytic Leukemia (Males) 0.55 0.64 0.58
Note: Bold text denotes the model ¯t with a result closest to the observed
value (displayed results are rounded to the second decimal).
In order to compare the two methods proposed for projection of future age-
adjusted cancer death rates, we modeled one-, two-, and three-year ahead projec-
tions for 2002 to 2004 based on data collected from 1969 to 2001. The observed
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age-adjusted cancer death rates for 2002, 2003, and 2004 are available and are
used to validate the prediction models. Table 1 displays the observed and pre-
dicted age-adjusted cancer death rates for the eight cancer sites with the highest
number of deaths (American Cancer Society, 2007). For both females and males,
the SSM method produced values closer to the observed age-adjusted cancer rates
than the PF method for each cancer site. The SSM outperformed the PF method
for all of the male types of cancer presented. One-, two-, and three-year-ahead
predicted age-adjusted cancer rates for all cancer sites combined are displayed in
Table 2.
Table 2: Observed and Three-year-ahead Predictions for all Sites Combined
for Females and Males for 2002 to 2004.
Observed PF SSM
Females 2002 162.87 168.43 162.10
Females 2003 160.45 166.78 163.23
Females 2004 156.96 164.19 160.78
Males 2002 240.20 244.52 240.03
Males 2003 234.12 238.74 236.51
Males 2004 228.26 233.11 231.34
Note: Bold text denotes the model ¯t with a result closest to the observed
value (displayed results are rounded to the second decimal).
Observed and three-year-ahead predicted cancer death counts as well as death
rates from the SSM and age-adjusted cancer death rates for breast cancer are
shown in Figures 2.
(a) (b)
Figure 2: Observed data (1999-2004) and 1-, 2-, and 3-year-ahead predicted
(2005-2007) count and rate values for breast cancer in females. (a) Female
breast counts; (b) female breast rates.
The count and rate ¯gures have appropriately scaled vertical axes so as to
display proportional changes between the two measures. The number of breast
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cancer deaths drops slightly over these years, although the population growth over
these years is more substantial, giving a more rapidly declining rate than count.
In contrast, the age-adjusted death rates show a steady decline over the same
years. This illustration shows the importance for policy-makers and clinicians to
consider both the number of deaths from cancer in the population and the death
rates that consider the population size as it changes over time. Studying one
without the other does not give a complete picture of the cancer death burden.
5. Discussion
This year, 559,650 Americans are expected to die of cancer (American Cancer
Society, 2007). Policymakers need current age-adjusted rate estimates alongside
the current age-adjusted count estimates, in order to make evidence-based policy
decisions that consider population size and change. The cancer burden is growing,
and based on age-adjusted incidence rates between 1998 and 2002, the number
of cancer patients is expected to more than double from 1.36 million in 2000 to
nearly 3.0 million in 2050 due to aging and the growing U.S. population (Hayat
et al., 2007).
National level age-adjusted death rates for the current year 2007 can be pre-
dicted based on observed data through 2004. We have described two statistical
modeling approaches for accomplishing this. Comparison of the two methods
was carried out using a weighted square deviation between the predicted and
observed one-, two-, and three-year-ahead age-adjusted rates, and the results
suggest the SSM model is performing better than the PF method. These results
are in agreement with the modeling results comparing the PF and SSM methods
for projecting national age-adjusted death counts (Tiwari et al., 2004).
The SSM method presented here assumes the error variance in the measure-
ment equation is constant. Assuming the counts are realizations of Poisson ran-
dom variables, the error variances can be assumed to be time dependent, and
given by
V ar(rt) =
JX
j=1
w2j
dtj
n2tj
:
However, our analysis (details not presented here) showed that this model did
not perform as well without the assumption of constant error variance. Further-
more, in order to implement the SSM method with non-constant error variance,
knowledge of the denominator, ntj , is needed for future years.
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